Wolverhampton CCG to Connect Pharmacies and GPs

EMISCommunity pharmacists and GPs in Wolverhampton will soon be able to offer joined up healthcare to thousands of patients, using cutting edge record-sharing technology. Wolverhampton clinical commissioning group (CCG) and EMIS Health have reached an agreement to jointly offer funding towards Pharmacy Access, a software package to enable local community pharmacies and GPs to securely share vital patient information and streamline the ordering and auditing of repeat prescriptions.

Pharmacies using the EMIS Health ProScript PMR system will be able to request repeat prescriptions electronically from GPs using the EMIS Web clinical system.

Pharmacists will also be able to view key clinical data in the GP record, including adverse reactions and allergies, historically prescribed acute and repeat medications, and test results such as the International Normalised Ratio (INR) thyroid function, blood pressure and blood sugars, amongst others. It will also facilitate advanced and enhanced services such as Medicines Use Reviews and the New Medicine Service.

The CCG is now inviting all 27 pharmacies and 35 GP practices in the area using ProScript and EMIS Web systems to roll out the technology.

The rollout will incorporate robust protocols to protect patient confidentiality. Patients must provide documented consent before the pharmacist can view their GP record. Access to the GP record within the pharmacy is governed by highly secure role-based access controls enforced by NHS Smart Cards.

Sheila Gregory, project implementation officer at Wolverhampton CCG said: "We are excited to be offering pharmacists Pharmacy Access, which shows what is possible with joined up healthcare. We look forward to measuring the clinical and administrative benefits over the next few months as the project gets up and running."

Ian Taylor, Managing Director of community pharmacy at EMIS Health said: "This is a timely project that supports the pharmacy profession's desire to play a greater role in the care of patients, through secure and relevant access to patient information.

"It will also benefit patients themselves, by better joining up their care."

Pharmacy Access is currently in place in over 150 other community pharmacies across the country.

Related news articles:

About EMIS Health
EMIS Health is part of EMIS Group plc - the UK leader in connected healthcare software and services.

EMIS Health provides software and services to clinicians working across every major UK healthcare setting, including:

  • Primary Care - market leader with 54% share of the UK GP market; its systems hold 40 million cradle to grave patient records;
  • Community Children's and Mental Health Care - 9% and growing UK market share;
  • Secondary Care - 81% of NHS Acute Trusts use an EMIS Health system; its software holds 30 million patient records in A&E alone;
  • Community Pharmacy - the single most used integrated community pharmacy and retail system (36% UK market share);
  • Specialist Care - EMIS Health is the leading provider of software and services to support diabetic eye screening (82% English market share) and other ophthalmology and specialist services.

EMIS Health is an innovator in secure data-sharing to join up healthcare. It was the first in the UK to enable community pharmacists to access information from the GP patient record - supporting safer dispensing - and the first to integrate personal health data captured on wearable consumer devices with the GP patient record.

Other businesses within EMIS Group are

  • Patient - the UK's leading provider of patient-centric medical and well-being information and related transactional services; www.patient.info attracts 18 million unique visitors a month.
  • Egton - providing specialist ICT infrastructure, software, hardware and engineering services.
  • EMIS Care - the new name for EMIS Group’s most recent acquisition, Medical Imaging, a specialist provider of grading and assessment services to support diabetic eye screening.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...